Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
Annals of Hematology|June 23, 2022
Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real-world, multi-center, matched analysisShai Shimony, Jonathan Canaani, Eitan Kugler, et al.
Annals of Hematology|January 1, 2017
Efficacy and safety of autologous hematopoietic cell transplantation in elderly patients with multiple myeloma: a retrospective national multi-site cohort studyYael C Cohen, Tsila Zuckerman, Moshe Yeshurun, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 15, 2014
Central nervous system relapse in adults with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantationAmir Hamdi, Raya Mawad, Roland Bassett, et al.
Annals of Hematology|June 22, 2022
Thrombopoietin receptor agonist for treating bone marrow aplasia following anti-CD19 CAR-T cells-single-center experienceOfrat Beyar-Katz, Chava Perry, Yael Bar On, et al.
Hematological Oncology|May 27, 2026
Belumosudil in the Management of Heavily Pretreated Prolonged Chronic GVHD: A Retrospective Multicenter Real-World StudyBen Varon, Ron Ram, Avichai Shimoni, et al.
European Journal of Haematology|October 17, 2022
The role of additional chemotherapy prior to autologous HCT in patients with relapse/refractory DLBCL in partial remission-A retrospective multicenter studyLiat Shargian, Odelia Amit, Hanna Bernstine, et al.
Bone Marrow Transplantation|March 24, 2020
Alternative donors provide comparable results to matched unrelated donors in patients with acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation in second complete remission: a report from the EBMT Acute Leukemia Working PartyEolia Brissot, Myriam Labopin, Domenico Russo, et al.
Respiration; International Review of Thoracic Diseases|June 30, 2025
Respiratory Burden in Hematology-Related Bronchiectasis: Clinical Characteristics and Treatable TraitsOphir Freund, Ori Wand, Yitzhac Hadad, et al.
American Journal of Hematology|November 2, 2013
Subcutaneous versus intravenous granulocyte colony stimulating factor for the treatment of neutropenia in hospitalized hemato-oncological patients: randomized controlled trialMical Paul, Ron Ram, Eitan Kugler, et al.
Haematologica|February 12, 2026
ICANS mitigation in high-risk elderly patients treated with CD28 co-stimulatory anti-CD19 CAR-T cells using a standardization protocol: a pilot studyGil Fridberg, Odelia Amit, Yehonathan Sherf, et al.
Pageof 13